A few days ago, CV Sciences Inc (OTCQB:CVSI) announced that it’s expanded its PlusCBd Oil brand, launching seven new body care products. At the time of writing, CV Sciences stock is trading in the red, down nearly 5%.
Here’s the latest with the cannabis company.
CV Sciences Stock: The Latest
On Tuesday, September 24, CV Sciences said it’s expanded its brand PlusCBD Oil, an industry-leading brand, by launching seven new body care products at Natural Products Expo East. According to CV Sciences CEO Joseph Dowling, the San Diego-based company is dedicated to offering high quality non-GMO full-spectrum hemp CBD products, and expanding its product line this month is all part of that plan.
“We are dedicated to offering the highest quality line of non-GMO full-spectrum hemp CBD products in the industry. Our seven new body care products continue to deliver on this promise and offer innovative solutions to those seeking alternatives to traditional body care.”
The list of products includes PlusCBD Oil raw hemp balm, gold hemp balm, and gold hemp skin serum. All of the products will be available in November, and each is US Hemp Authority Certified. They are also all free from gluten and artificial dyes. The news comes just as CV Sciences Inc acquired the “NEXTY Consumer Choice Award” in the Supplement Category.
Despite the good news, CV Sciences stock is trading in the red Friday.
According to Yahoo Finance, as of 11:23 AM EDT, CVSI stock is trading at $2.05, which puts CV Sciences stock down 4.65%. It is, of course, not the only cannabis stock trading down Friday. Cannabis stocks are relatively mixed going into the weekend.
What do you think about CV Sciences expanding its product line? Will this bring future successes to CV Sciences stock once the products are available in November? Let us know your thoughts in the comments below.
Featured image: PixaBay